...
【24h】

Topical otic antibiotics: clinical cochlear ototoxicity and cost consideration.

机译:局部耳用抗生素:临床耳蜗的耳毒性和成本考虑。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Determine the incidence of clinical cochlear ototoxicity in routine use of Cortisporin after ventilation tube placement. Cost differential between use of Cortisporin and fluoroquinolone agents was evaluated. METHODS: A retrospective review of 500 patients was performed. Cortisporin otic suspension was used for 5 days following ventilation tube insertion. RESULTS: Testing following surgery indicated a sensorineural hearing loss (SNHL) in 19 (2.1%) ears. The SNHL existed prior to the surgery and there was no deterioration in the hearing postoperatively. The total cost for our study group who used Cortisporin was Dollars 15,500. If Floxin had been prescribed the cost would have been Dollars 45,000. Had Ciprodex been prescribed, the cost would have been Dollars 49,500. CONCLUSION: Our study demonstrates no clinical cochlear ototoxicity in children who received Cortisporin following ventilation tube placement. The cost differential for prescribing fluoroquinolone drops is significant. EBM rating:C-4.
机译:目的:确定通气管放置后常规使用皮质醇的临床耳蜗耳毒性的发生率。评估了在使用Cortisporin和氟喹诺酮类药物之间的成本差异。方法:对500例患者进行回顾性回顾。在通气管插入后,将Cortisporin耳悬液使用5天。结果:手术后的测试表明19只(2.1%)的耳朵有感觉神经性听力损失(SNHL)。 SNHL在手术前就已存在,术后听力没有恶化。使用Cortisporin的研究组的总费用为15,500美元。如果开处方了氟辛,则费用将为45,000美元。如果开具Ciprodex的处方,则费用为49,500美元。结论:我们的研究表明通气管放置后接受皮质醇治疗的儿童无临床耳蜗耳毒性。处方氟喹诺酮滴剂的成本差异很大。 EBM等级:C-4。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号